- Home
- KZIA vs ATXG Comparison
KZIA vs ATXG Comparison
Compare KZIA & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- ATXG
- Stock Information
- Founded
- KZIA 1994
- ATXG 2014
- Country
- KZIA Australia
- ATXG China
- Employees
- KZIA N/A
- ATXG N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- ATXG Professional Services
- Sector
- KZIA Health Care
- ATXG Consumer Discretionary
- Exchange
- KZIA Nasdaq
- ATXG Nasdaq
- Market Cap
- KZIA 6.0M
- ATXG 5.4M
- IPO Year
- KZIA 1999
- ATXG N/A
- Fundamental
- Price
- KZIA $0.77
- ATXG $0.80
- Analyst Decision
- KZIA Strong Buy
- ATXG
- Analyst Count
- KZIA 2
- ATXG 0
- Target Price
- KZIA $11.50
- ATXG N/A
- AVG Volume (30 Days)
- KZIA 334.9K
- ATXG 5.8K
- Earning Date
- KZIA 04-11-2025
- ATXG 02-14-2025
- Dividend Yield
- KZIA N/A
- ATXG N/A
- EPS Growth
- KZIA N/A
- ATXG N/A
- EPS
- KZIA N/A
- ATXG N/A
- Revenue
- KZIA $1,655,324.00
- ATXG $4,549,310.00
- Revenue This Year
- KZIA N/A
- ATXG N/A
- Revenue Next Year
- KZIA N/A
- ATXG N/A
- P/E Ratio
- KZIA N/A
- ATXG N/A
- Revenue Growth
- KZIA 248000.00
- ATXG N/A
- 52 Week Low
- KZIA $0.76
- ATXG $0.49
- 52 Week High
- KZIA $15.80
- ATXG $1.18
- Technical
- Relative Strength Index (RSI)
- KZIA 35.51
- ATXG 45.81
- Support Level
- KZIA $0.76
- ATXG $0.79
- Resistance Level
- KZIA $1.05
- ATXG $0.89
- Average True Range (ATR)
- KZIA 0.08
- ATXG 0.06
- MACD
- KZIA -0.00
- ATXG -0.00
- Stochastic Oscillator
- KZIA 3.84
- ATXG 33.48
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.